Program Areas

Program areas under the Renewed Canadian HIV Vaccine Initiative are:

• Advancing Basic Science - activities will be supported to strengthen the capacity of and promote greater involvement and collaboration amongst researchers in Canada and in low-and-middle-income countries who are working in HIV vaccine discovery and social research.
• Translating Basic Science into Clinical Trials - activities will be supported to assist researchers, in the public and private sectors, in moving promising HIV vaccine candidates from preclinical research into clinical trials in humans.
• Addressing Enabling Conditions - activities will be supported that involve domestic and international stakeholders in addressing HIV vaccines policy issues, building capacity and promoting global harmonization of regulatory pathways, and improving preparedness.
• Preventing Mother-to-Child Transmission of HIV - activities will be supported that will improve the efficacy and effectiveness of PMTCT in low-and-middle-income countries, by enhancing the availability, quality and uptake of PMTCT services.
• Supporting a Coordinated Approach (GoC and Alliance) - activities will provide coordination support and infrastructure to ensure a strong network of HIV vaccine researchers and other vaccine researchers both in Canada and internationally; and ensure effective communications, strategic planning, coordination, reporting and evaluation within the Government of Canada.

Program areas

Key Areas of Focus		GoC	BMGF	Total
HIV Vaccines	Advancing Basic Science	$27M	$7M	$34M
	Translating Research into Clinical Trials	$34M	$14M	$48M
	Addressing Enabling Conditions	$13M	$7M	$20M
Prevention of Mother-to-Child Transmission of HIV		$30M	$0	$30M
Supporting a Coordinated Approach (GoC and Alliance)		$7M	$0	$7M
Total		$111M	$28M	$139M